4//SEC Filing
Giesing Dennis H 4
Accession 0001104659-21-075233
CIK 0001472012other
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 7:16 PM ET
Size
5.4 KB
Accession
0001104659-21-075233
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Giesing Dennis H
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-05-28+16,609→ 16,609 totalExercise: $20.92Exp: 2031-05-28→ Common Stock (16,609 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on May 28, 2022, and one-thirty-sixth (1/36th) of the remaining shares subject to the option shall vest every month thereafter.
Documents
Issuer
Immunome Inc.
CIK 0001472012
Entity typeother
Related Parties
1- filerCIK 0001853622
Filing Metadata
- Form type
- 4
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 7:16 PM ET
- Size
- 5.4 KB